Research map: Unified genetic risk score for prostate cancer enables improved risk stratification for clinical decision-making

Back to the article

Papers in this map

  1. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Sue M. Richards · 2015 · 33500 citations · Cited by this paper
  2. Longest surviving patient with a homozygous splice-altering EGFR pathogenic variant presenting with skin autoinflammation and a Bartter-like salt-losing tubulopathy · 2026 · Related
  3. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  4. PRS-BC 313 integration for tailored breast cancer prevention in female patients and their healthy relatives · 2026 · Related
  5. The UK Biobank resource with deep phenotyping and genomic data · Clare Bycroft · 2018 · 10126 citations · Cited by this paper
  6. Mosaic variegated aneuploidy as a novel feature in patients with Mulibrey nanism and TRIM37 variants · 2026 · Related
  7. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines · Quan Li · 2017 · 1120 citations · Cited by this paper
  8. Interpreting TP53 variants: somatic mosaicism and ERCC6L2 -driven clonal evolution · 2026 · Related
  9. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries · Lorelei Ann Mucci · 2016 · 971 citations · Cited by this paper
  10. Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages · 2026 · Related
  11. The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation · Samuel A. Lambert · 2021 · 775 citations · Cited by this paper
  12. Review of estimates of birth incidence and population prevalence over time and between countries of the rare neurodevelopmental condition Prader-Willi syndrome · 2026 · Related
  13. Cumulative Association of Five Genetic Variants with Prostate Cancer · S. Lilly Zheng · 2008 · 635 citations · Cited by this paper
  14. The SINEs were there: identification of a pathogenic Alu insertion in a patient with DICER1-related tumour predisposition · 2026 · Related
  15. Prostate-Specific Antigen–Based Screening for Prostate Cancer · Joshua J. Fenton · 2018 · 566 citations · Cited by this paper
  16. ACAN -related disorder, antenatal presentation and phenotypic variability: a case series · 2026 · Related
  17. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction · David V. Conti · 2021 · 511 citations · Cited by this paper
  18. Clinical manifestations of chromosome 19p13.11 duplication · 2026 · Related
  19. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening · John Thomas Wei · 2023 · 387 citations · Cited by this paper
  20. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016 · Peter R. Carroll · 2016 · 347 citations · Cited by this paper
  21. Prostate Cancer · Ruben Raychaudhuri · 2025 · 345 citations · Cited by this paper
  22. Prostate Cancer, Version 3.2024 · Edward Matthew Schaeffer · 2024 · 302 citations · Cited by this paper
  23. Individual and cumulative effect of prostate cancer risk‐associated variants on clinicopathologic variables in 5,895 prostate cancer patients · A. Karim Kader · 2009 · 106 citations · Cited by this paper
  24. European Study of Prostate Cancer Screening — 23-Year Follow-up · Monique J. Roobol · 2025 · 95 citations · Cited by this paper
  25. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations · Minh‐Phuong Huynh‐Le · 2021 · 78 citations · Cited by this paper
  26. Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer · Thomas Callender · 2021 · 62 citations · Cited by this paper
  27. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis · Zhuqing Shi · 2020 · 60 citations · Cited by this paper
  28. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer · Burcu F. Darst · 2023 · 57 citations · Cited by this paper
  29. Prostate cancer polygenic risk score and prediction of lethal prostate cancer · Robert J. Klein · 2022 · 52 citations · Cited by this paper
  30. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program · Meghana S. Pagadala · 2022 · 38 citations · Cited by this paper
  31. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations · Fei Chen · 2022 · 36 citations · Cited by this paper
  32. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry · Burcu F. Darst · 2023 · 28 citations · Cited by this paper
  33. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026 · Heather H. Cheng · 2026 · 28 citations · Cited by this paper
  34. Gene-based burden tests of rare germline variants identify six cancer susceptibility genes · Erna V. Ivarsdottir · 2024 · 27 citations · Cited by this paper
  35. Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies · Jianfeng Xu · 2022 · 20 citations · Cited by this paper
  36. Using clinical and genetic risk factors for risk prediction of 8 cancers in the UK Biobank · Jiaqi Hu · 2024 · 18 citations · Cited by this paper
  37. Imaging in Diagnosis and Active Surveillance for Prostate Cancer · Thomas Li · 2024 · 16 citations · Cited by this paper
  38. Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases · Jonathan Mitchell · 2025 · 16 citations · Cited by this paper
  39. Germline Testing for Prostate Cancer Patients: Evidence‐Based Evaluation of Genes Recommended by NCCN Guidelines · Jianfeng Xu · 2025 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)